Chargement en cours...
KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
Malignant gliomas are among the most frequent and aggressive cerebral tumors, characterized by high proliferative and invasive indexes. Standard therapy for patients, after surgery and radiotherapy, consists of temozolomide (TMZ), a methylating agent that blocks tumor cell proliferation. Currently,...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058717/ https://ncbi.nlm.nih.gov/pubmed/27096953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8761 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|